Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Brand-name prescription medicine

Corphena

Generic name: Dexchlorpheniramine maleate

FDA application holder: Pharmobedient

Official data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the NDC Directory, Drugs@FDA, the official labels and recall reports; pharmacy costs come from the Centers for Medicare & Medicaid Services (CMS). Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or switch any medicine, including a switch between a brand and a generic.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Corphena?
Corphena is a brand name of Dexchlorpheniramine maleate, a prescription medicine. The FDA NDC Directory lists 1 Corphena product in 1 strength and form.
Who makes Corphena?
Pharmobedient holds the FDA application for Corphena (ANDA202520, approved July 16, 2018).
Is there a generic or store brand of Corphena?
Other products of Dexchlorpheniramine maleate are listed with the FDA, but none in exactly the same strength and form as a Corphena product.
Has Corphena been recalled?
No recall linked to Corphena products (by their NDC code or label) appears in the FDA enforcement reports we use.

What Corphena is

Each Corphena product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.

Dexchlorpheniramine maleate · prescription medicine

Strength and formProduct namesSame medicine, other namesLabel
dexchlorpheniramine maleate 2 mg/5 mL
solution (oral)
Corphena None listed —

Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Dexchlorpheniramine maleate →

FDA approval

  • ANDA: Abbreviated New Drug Application: how a generic version is approved.
FDA applications of Corphena products (Drugs@FDA)
ApplicationHolderFirst approvedProducts
ANDA202520PharmobedientJuly 16, 20181

Companies that list Corphena

The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Corphena products.

Recalls

No recall linked to Corphena products (by their NDC code or label) appears in the FDA enforcement reports.

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026

Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.

Report an error → · Information for medicine makers